Best Read Drugs Headlines
Headlines from our Drugs Topic Page with the most time spent reading.
#1 Beshear Bans Designer Xanax Drug in Kentucky as AGs Urge Emergency Action
Aug 20 2025 // Kentucky Gov. Andy Beshear took emergency action Monday to ban the sale of “designer Xanax,” responding to a request from his state’s attorney general who is leading a broader effort to combat the highly...
#2 Top FDA Drug Regulator Leaves, Agency Cites Personal Conduct
Nov 5 2025 // The US Food and Drug Administration’s lead drug regulator George Tidmarsh resigned two days after being placed on administrative leave over personal conduct concerns, according to the US Department of Health and...
#3 Bristol Myers Reaches $239 Million Settlement Over Psoriasis, MS Drugs
Nov 7 2025 // Bristol Myers Squibb reached a $239 million settlement of claims that former Celgene shareholders were defrauded about prospects for the psoriasis drug Otezla, and multiple sclerosis treatment now known as Zeposia. A...
#4 Trump Vows No Tariff Extension, Hardens Threats on Copper, Drugs
Jul 9 2025 // President Donald Trump vowed to push forward with his aggressive tariff regime in the coming days, stressing he would not offer additional extensions on country-specific levies set to now hit in early August while...
#5 How Hurricanes, Fires and Floods Put Drugs and Medical Supplies at Risk
Aug 22 2025 // When Hurricane Helene barreled across several southern states last fall, it destroyed homes and killed more than 150 people. The storm also took out one of the country’s main factories producing intravenous fluid...
#6 California Highway Patrol Blames Drug Use, Speeding for Cybertruck Crash That Killed 3
Mar 5 2025 // Drug use and excessive speed were to blame for last year’s fiery crash of a Tesla Cybertruck that killed three college students near San Francisco, the California Highway Patrol said in a preliminary report. Four...
#7 Dermatologicals Now the Costliest Drug Group in California Workers Comp
Jan 15 2025 // Dermatologicals, which include a number of high-priced, private label drugs, account for the biggest share of the total drug spend in the California workers’ compensation system, a new report shows. Data from the...
#8 Florida Seeks Personal Prescription Data From Drug Middlemen
Mar 4 2025 // Florida insurance regulators have asked companies to hand over extensive amounts of data on people’s pharmacy claims, including personal information and prescription drug usage, an unusual move for a state regulator...
#9 Swiss Re Tackles Longevity Drug Impact With Life Policy Advice
Aug 12 2025 // Swiss Re AG issued guidance for underwriters on how to assess life insurance applications of people who show signs of using medications for longevity purposes. Metformin, traditionally used to manage type 2 diabetes, and...
#10 Judge Rules Boston Waited Too Long to Sue Drug Intermediaries Over Opioid Crisis
Feb 13 2025 // A federal judge has dismissed the city of Boston’s lawsuit seeking to hold pharmacy benefit managers liable for the opioid epidemic. US District Judge Patti B. Saris ruled that the suit against the drug...
#11 NC Woman Faces 170 Felony Charges in Insurance Fraud Involving Stolen GLP-1 Drugs
Oct 10 2025 // A North Carolina woman has been busy over the last three years, illegally obtaining weight-loss medication, administering it to people, and defrauding insurance companies of more than $87,400, the state Department of...
#12 Drug Companies Paying Hawaii $700 Million to Settle Plavix Blood Thinner Suit
May 12 2025 // Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general’s office announced. A court ruling last year...
#13 Lilly Sues 4 Compounders Over Copies of Weight-Loss Drugs
Apr 24 2025 // Eli Lilly said Wednesday it had sued four compounders for selling unapproved products containing tirzepatide, after a U.S. judge last month blocked pharmacies from making copies of its weight-loss and diabetes...
#14 Jazz Pharma to Pay $145 Million to Settle Narcolepsy Drug Antitrust Case
Apr 9 2025 // Jazz Pharmaceuticals said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its narcolepsy drug, Xyrem. Xyrem, a medication approved in the U.S., is used for...
#15 Texas Sues Tylenol Makers J&J and Kenvue, Alleging They Hid Drug’s Autism Risks
Oct 28 2025 // The makers of Tylenol, Johnson & Johnson JNJ.N and Kenvue KVUE.N, were sued on Tuesday by Texas Attorney General Ken Paxton, who accused them of knowingly hiding the drug’s links to autism and attention deficit...
